Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations

Journal of Alzheimer's Disease

Volumn 9, Issue 2, 2006, Pages 139-146

  Keil, Uta ^a   Hauptmann, Susanne ^a   Bonert, Astrid ^a   Scherping, Isabel ^a   Eckert, Anne ^b   Müller, Walter E ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer's disease; Amyloid ; Amyloid protein precursor; Mitochondria; Oxidative stress; Tau

Indexed keywords

AMYLOID PRECURSOR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN; CHEMICAL ANALYSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; MEDICAL RESEARCH; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; STATISTICAL SIGNIFICANCE; SYNAPTIC TRANSMISSION; THROMBOCYTE;

EID: 33746103234     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9206     Document Type: Review

References (74)

1. P. Friedhoff, M. von Bergen, E.M. Mandelkow and E. Mandelkow, Structure of tau protein and assembly into paired helical filaments, Biochim. Biophys. Acta 1502 (2000), 122-132.
2. J. Hardy and D.J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 (2002), 353-356.
3. C. Haass, Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation, EMBO J. 23 (2004), 483-488.
4. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe and S. Younkin, Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and AβPP mutations linked to familial Alzheimer's disease, Nat. Med. 2 (1996), 864-870.
5. M. Citron, T. Oltersdorf, C. Haass, L. McConlogue, A.Y. Hung, P. Seubert, C. Vigo-Pelfrey, I. Lieberburg and D.J. Selkoe, Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production, Nature 360 (1992), 672-674.
6. C. Haass, A.Y. Hung, D.J. Selkoe and D.B. Teplow, Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor, J. Biol. Chem, 269 (1994), 17741-17748.
7. A. Lleo, O. Berezovska, J.H. Growdon and B.T. Hyman, Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations, Am. J. Geriatr. Psychiatry 12 (2004), 146-156.
8. D. Neary, J. Snowden and D. Mann, Frontotemporal dementia, Lancet Neurol. 4 (2005), 771-780.
9. J. Gotz, F. Chen, R. Barmettler and R.M. Nitsch, Tau filament formation in transgenic mice expressing P301L tau, J. Biol. Chem. 276 (2001), 529-534.
10. M.F. Beal, B.T. Hyman and W. Koroshetz, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci. 16 (1993), 125-131.
11. M.F. Beal, Energetics in the pathogenesis of neurodegenerative diseases, Trends Neurosci. 23 (2000), 298-304.
12. S. Hoyer, Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update, Exp. Gerontol. 35 (2000), 1363-1372.
13. J.P. Blass, G.E. Gibson and S. Hoyer, The role of the metabolic lesion in Alzheimer's disease, J. Alzheimers. Dis. 4 (2002), 225-232.
14. P. Chagnon, C. Betard, Y. Robitaille, A. Cholette and D. Gauvreau, Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases, Neuroreport 6 (1995), 711-715.
15. W.D. Parker, Jr., J. Parks, C.M. Filley and B.K. Kleinschmidt-DeMasters, Electron transport chain defects in Alzheimer's disease brain, Neurology 44 (1994), 1090-1096.
16. W.D. Parker, Jr., Cytochrome oxidase deficiency in Alzheimer's disease, Ann. N. Y. Acad. Sci. 640 (1991), 59-64.
17. I. Maurer, S. Zierz and H.J. Moller, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, Neurobiol. Aging 21 (2000), 455-462.
18. D.A. Cottrell, G.M. Borthwick, M.A. Johnson, P.G. Ince and D.M. Turnbull, The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease, Neuropathol. Appl. Neurobiol. 28 (2002), 390-396.
19. P. Bubber, V. Haroutunian, G. Fisch, J.P. Blass and G.E. Gibson, Mitochondrial abnormalities in Alzheimer brain: mechanistic implications, Ann. Neurol. 57 (2005), 695-703.
20. K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R.L. Russell, C.S. Atwood, A.B. Johnson, Y. Kress, H.V. Vinters, M. Tabaton, S. Shimohama, A.D. Cash, S.L. Siedlak, P.L. Harris, P.K. Jones, R.B. Petersen, G. Perry and M.A. Smith, Mitochondrial abnormalities in Alzheimer's disease, J. Neurosci. 21 (2001), 3017-3023.
21. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan and H. Wu, ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease, Science 304 (2004), 448-452.
22. P. Fernandez-Vizarra, A.P. Fernandez, S. Castro-Blanco, J. Serrano, M.L. Bentura, R. Martinez-Murillo, A. Martinez and J. Rodrigo, Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease, Histol. Histopathol. 19 (2004), 823-844.
23. S.M. Cardoso, M.T. Proenca, S. Santos, I. Santana and C.R. Oliveira, Cytochrome c oxidase is decreased in Alzheimer's disease platelets, Neurobiol. Aging 25 (2004), 105-110.
24. F. Bosetti, F. Brizzi, S. Barogi, M. Mancuso, G. Siciliano, E.A. Tendi, L. Murri, S.I. Rapoport and G. Solaini, Cytochrome c oxidase and mitochondrial F(1)F(0)-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease, Neurobiol. Aging 23 (2002), 371-376.
25. M. Mancuso, M. Filosto, F. Bosetti, R. Ceravolo, A. Rocchi, G. Tognoni, M.L. Manca, G. Solaini, G. Siciliano and L. Murri, Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease, Exp. Neurol. 182 (2003), 421-426.
26. S.M. Khan, D.S. Cassarino, N.N. Abramova, P.M. Keeney, M.K. Borland, P.A. Trimmer, C.T. Krebs, J.C. Bennett, J.K. Parks, R.H. Swerdlow, W.D. Parker, Jr. and J.P. Bennett, Jr., Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways, Ann. Neurol. 48 (2000), 148-155.
27. P.A. Trimmer, P.M. Keeney, M.K. Borland, F.A. Simon, J. Almeida, R.H. Swerdlow, J.P. Parks, W.D. Parker, Jr. and J.P. Bennett, Jr., Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture, Neurobiol. Dis. 15 (2004), 29-39.
28. S.M. Cardoso, I. Santana, R.H. Swerdlow and C.R. Oliveira, Mitochondria dysfunction of Alzheimer's disease cybrids enhances Abeta toxicity, J. Neurochem. 89 (2004), 1417-1426.
29. L. Canevari, J.B. Clark and T.E. Bates, beta-Amyloid fragment 25-35 selectively decreases complex IV activity in isolated mitochondria, FEBS Lett. 457 (1999), 131-134.
30. C.S. Casley, L. Canevari, J.M. Land, J.B. Clark and M.A. Sharpe, Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities, J. Neurochem. 80 (2002), 91-100.
31. P.J. Crouch, R. Blake, J.A. Duce, G.D. Ciccotosto, Q.X. Li, K.J. Barnham, C.C. Curtain, R.A. Cherny, R. Cappai, T. Dyrks, C.L. Masters and I.A. Trounce, Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42, J. Neurosci. 25 (2005), 672-679.
32. H.S. Kim, J.H. Lee, J.P. Lee, E.M. Kim, K.A. Chang, C.H. Park, S.J. Jeong, M.C. Wittendorp, J.H. Seo, S.H. Choi and Y.H. Suh, Amyloid beta peptide induces cytochrome C release from isolated mitochondria, Neuroreport 13 (2002), 1989-1993.
33. A.M. Aleardi, G. Benard, O. Augereau, M. Malgat, J.C. Talbot, J.P. Mazat, T. Letellier, J. Dachary-Prigent, G.C. Solaini and R. Rossignol, Gradual Alteration of Mitochondrial Structure and Function by beta-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release, J. Bioenerg. Biomembr. 37 (2005), 207-225.
34. P.I. Moreira, M.S. Santos, A. Moreno, A.C. Rego and C. Oliveira, Effect of amyloid beta-peptide on permeability transition pore: a comparative study, J. Neurosci. Res. 69 (2002), 257-267.
35. P.I. Moreira, M.S. Santos, A. Moreno and C. Oliveira, Amyloid beta-peptide promotes permeability transition pore in brain mitochondria, Biosci. Rep. 21 (2001), 789-800.
36. E.F. Shevtzova, E.G. Kireeva and S.O. Bachurin, Effect of beta-amyloid peptide fragment 25-35 on nonselective permeability of mitochondria, Bull. Exp. Biol. Med. 132 (2001), 1173-1176.
37. C.S. Casley, J.M. Land, M.A. Sharpe, J.B. Clark, M.R. Duchen and L. Canevari, Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons, Neurobiol. Dis. 10 (2002), 258-267.
38. R.H. Swerdlow and S.J. Kish, Mitochondria in Alzheimer's disease, Int. Rev. Neurobiol. 53 (2002), 341-385.
39. D.S. Cassarino and J.P. Bennett, Jr., An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration, Brain Res. Brain Res. Rev. 29 (1999), 1-25.
40. C. Pereira, M.S. Santos and C. Oliveira, Mitochondrial function impairment induced by amyloid beta-peptide on PC12 cells, Neuroreport 9 (1998), 1749-1755.
41. C. Pereira, M.S. Santos and C. Oliveira, Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants, Neurobiol. Dis. 6 (1999), 209-219.
42. A.Y. Abramov, L. Canevari and M.R. Duchen, Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase, J. Neurosci. 24 (2004), 565-575.
43. C.A. Marques, U. Keil, A. Bonert, B. Steiner, C. Haass, W.E. Muller and A. Eckert, Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway, J. Biol. Chem. 278 (2003), 28294-28302.
44. U. Keil, A. Bonert, C.A. Marques, I. Scherping, J. Weyermann, J.B. Strosznajder, F. Muller-Spahn, C. Haass, C. Czech, L. Pradier, W.E. Muller and A. Eckert, Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis, J. Biol. Chem. 279 (2004), 50310-50320.
45. S.M. Grant, S.L. Shankar, R.M. Chalmers-Redman, W.G. Tatton, M. Szyf and A.C. Cuello, Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAβPP751), Neuroreport 10 (1999), 41-46.
46. H.K. Anandatheerthavarada, G. Biswas, M.A. Robin and N.G. Avadhani, Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells, J. Cell Biol. 161 (2003), 41-54.
47. N. Sato, K. Kamino, K. Tateishi, T. Satoh, Y. Nishiwaki, A. Yoshiiwa, T. Miki and T. Ogihara, Elevated amyloid beta protein(1-40) level induces CREB phosphorylation at serine-133 via p44/42 MAP kinase (Erk1/2)-dependent pathway in rat pheochromocytoma PC12 cells, Biochem. Biophys. Res. Commun. 232 (1997), 637-642.
48. M.R. Kibbe, J. Li, S. Nie, S.C. Watkins, A. Lizonova, I. Kovesdi, R.L. Simmons, T.R. Billiar and E. Tzeng, Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate, J. Vasc. Surg. 31 (2000), 1214-1228.
49. H. Atamna and W.H. Frey, A role for heme in Alzheimer's disease: heme binds amyloid beta and has altered metabolism, Proc. Natl. Acad. Sci. USA 101 (2004), 11153-11158.
50. H. Atamna, D.W. Killilea, A.N. Killilea and B.N. Ames, Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging, Proc. Natl. Acad. Sci. USA 99 (2002), 14807-14812.
51. H. Atamna, J. Liu and B.N. Ames, Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: revelance to aging, J. Biol. Chem. 276 (2001), 48410-48416.
52. P. Kienlen-Campard, S. Miolet, B. Tasiaux and J.N. Octave, Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid- beta peptides, induces neuronal apoptosis, J. Biol. Chem. 277 (2002), 15666-15670.
53. L.M. Billings, S. Oddo, K.N. Green, J.L. McGaugh and F.M. LaFerla, Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron 45 (2005), 675-688.
54. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe and K.H. Ashe, Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function, Nat. Neurosci. 8 (2005), 79-84.
55. M.A. Smith, C.A. Rottkamp, A. Nunomura, A.K. Raina and G. Perry, Oxidative stress in Alzheimer's disease, Biochim. Biophys. Acta 1502 (2000), 139-144.
56. A. Nunomura, G. Perry, G. Aliev, K. Hirai, A. Takeda, E.K. Balraj, P.K. Jones, H. Ghanbari, T. Wataya, S. Shimohama, S. Chiba, C.S. Atwood, R.B. Petersen and M.A. Smith, Oxidative damage is the earliest event in Alzheimer disease, J. Neuropathol. Exp. Neurol. 60 (2001), 759-767.
57. W.R. Markesbery, Oxidative stress hypothesis in Alzheimer's disease, Free Radic. Biol. Med. 23 (1997), 134-147.
58. A. Eckert, B. Steiner, C. Marques, S. Leutz, H. Romig, C. Haass and W.E. Muller, Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation, J. Neurosci. Res. 64 (2001), 183-192.
59. S. Leutz, B. Steiner, C.A. Marques, C. Haass, W.E. Muller and A. Eckert, Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer's AβPP mutation and sensitizes cells to staurosporine-induced cell death, J. Mol. Neurosci. 18 (2002), 189-201.
60. V. Blanchard, S. Moussaoui, C. Czech, N. Touchet, B. Bonici, M. Planche, T. Canton, I. Jedidi, M. Gohin, O. Wirths, T.A. Bayer, D. Langui, C. Duyckaerts, G. Tremp and L. Pradier, Time sequence of maturation of dystrophic neurites associated with Abeta deposits in AβPP/PS1 transgenic mice, Exp. Neurol. 184 (2003), 247-263.
61. C.A. Hansson, S. Frykman, M.R. Farmery, L.O. Tjernberg, C. Nilsberth, S.E. Pursglove, A. Ito, B. Winblad, R.F. Cowburn, J. Thyberg and M. Ankarcrona, Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria, J. Biol. Chem. 279 (2004), 51654-51660.
62. K. Schuessel, S. Schafer, T.A. Bayer, C. Czech, L. Pradier, F. Muller-Spahn, W.E. Muller and A. Eckert, Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in AβPP transgenic mice, Neurobioi. Dis. 18 (2005), 89-99.
63. Z. Zhao, L. Ho, J. Suh, W. Qin, H. Pyo, P. Pompl, H. Ksiezak-Reding and G.M. Pasinetti, A role of P301L tau mutant in anti-apoptotic gene expression, cell cycle and apoptosis, Mol. Cell Neurosci. 24 (2003), 367-379.
64. I. Khlistunova, J. Biernat, Y. Wang, M. Pickhardt, M. von Bergen, Z. Gazova, E. Mandelkow and E.M. Mandelkow, Inducible expression of tau repeat domain in cell models of tauopathy: Aggregation is toxic to cells but can be reversed by inhibitor drugs, J. Biol. Chem. 281 (2006), 1205-1214.
65. D.C. David, S. Hauptmann, I. Scherping, K. Schuessel, U. Keil, P. Rizzu, R. Ravid, S. Drose, U. Brandt, W.E. Muller, A. Eckert and J. Gotz, Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice, J. Biol. Chem. 280 (2005), 23802-23814.
66. A. Eckert, K. Schindowski, S. Leutner, C. Luckhaus, N. Touchet, C. Czech and W.E. Muller, Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice, Neurobiol. Dis. 8 (2001), 331-342.
67. K. Schuessel, C. Frey, C. Jourdan, U. Keil, C. C. Weber, F. Müller-Spahn, W.E. Müller and A. Eckert, Aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice, Free Radic. Biol. Med. 40 (2006), 850-862.
68. A. Ferrari, F. Hoerndli, T. Baechi, R.M. Nitsch and J. Gotz, beta-Amyloid induces paired helical filament-like tau filaments in tissue culture, J. Biol. Chem. 278 (2003), 40162-40168.
69. J. Gotz, F. Chen, J. van Dorpe and R.M. Nitsch, Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils, Science 293 (2001), 1491-1495.
70. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen, N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton and E. McGowan, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and AβPP, Science 293 (2001), 1487-1491.
71. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari and F.M. LaFerla, Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron 39 (2003), 409-421.
72. S. Oddo, L. Billings, J.P. Kesslak, D.H. Cribbs and F.M. LaFerla, Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome, Neuron 43 (2004), 321-332.
73. S. Oddo, A. Caccamo, L. Tran, M.P. Lambert, C.G. Glabe, W.L. Klein and F.M. LaFerla, Temporal Profile of Amyloid-beta (Abeta) Oligomerization in an in Vivo Model of Alzheimer Disease: A link between Abeta And tau pathology, J. Biol. Chem. 281 (2006), 1599-1604.
74. S. Hauptmann, U. Keil, I. Scherping, A. Bonert, A. Eckert and W.E. Müller, Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease, Exp. Gerontol (2006), in press.